New Nordic Healthbrands AB (SE:NNH)
:NNH
Want to see SE:NNH full AI Analyst Report?
NNH Stock Chart & Stats
kr21.50
kr0.00(0.00%)
At close: 4:00 PM EST
kr21.50
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr12.95 - kr28.00
Previous CloseN/A
Volume5.00K
Average Volume (3M)5.45K
Market Cap
kr84.56M
Enterprise Valuekr122.07M
Total Cash (Recent Filing)kr8.66M
Total Debt (Recent Filing)kr39.66M
Price to Earnings (P/E)30.2
Beta0.26
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.43
Shares Outstanding6,195,200
10 Day Avg. Volume3,153
30 Day Avg. Volume5,451
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.39
Price to Sales (P/S)0.25
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthReported debt-to-equity in the ~0.25–0.43 range and stable equity indicate a conservative capital structure. This provides financial flexibility to absorb shocks, fund working capital or targeted marketing investments, and reduces refinancing risk during cyclical volatility.
Return To ProfitabilityThe company regained profitability after multi-year losses, producing positive net results in 2025 and TTM 2026. A sustained earnings base improves ability to fund operations internally, supports credibility with partners, and is a prerequisite for durable margin recovery and reinvestment.
Improving Cash Conversion When ProfitableFree cash flow to net income around 0.8–0.9 indicates that profits largely convert to cash in recent periods. That structural cash conversion ability, when maintained, supports capex, dividends or debt reduction and reduces reliance on external financing for steady investments.
Bears Say
Thin Profit MarginsVery narrow EBIT and net margins leave little room for cost inflation, pricing pressure, or execution errors. Such thin profitability constrains internal reinvestment, limits resilience to adverse input-cost swings, and makes sustainable margin improvement challenging.
Recent Revenue WeaknessA shift to slightly negative TTM revenue growth signals weakening demand or adverse mix trends. For a branded consumer-goods firm, sustained top-line softness undermines operating leverage, complicates margin recovery and may require increased spending to defend market share.
Volatile Cash GenerationHistoric swings in operating cash flow and a sharp FCF decline in the TTM reduce predictability of internal funding. That volatility raises execution risk for growth plans, increases dependency on external financing in downcycles, and complicates long-term capital allocation.
NNH FAQ
What was New Nordic Healthbrands AB’s price range in the past 12 months?
New Nordic Healthbrands AB lowest stock price was kr12.95 and its highest was kr28.00 in the past 12 months.
What is New Nordic Healthbrands AB’s market cap?
New Nordic Healthbrands AB’s market cap is kr84.56M.
When is New Nordic Healthbrands AB’s upcoming earnings report date?
New Nordic Healthbrands AB’s upcoming earnings report date is Aug 05, 2026 which is in 53 days.
How were New Nordic Healthbrands AB’s earnings last quarter?
New Nordic Healthbrands AB released its earnings results on Apr 29, 2026. The company reported -kr0.462 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.462.
Is New Nordic Healthbrands AB overvalued?
According to Wall Street analysts New Nordic Healthbrands AB’s price is currently Overvalued.
Does New Nordic Healthbrands AB pay dividends?
New Nordic Healthbrands AB pays a Annually dividend of kr0.25 which represents an annual dividend yield of N/A. See more information on New Nordic Healthbrands AB dividends here
What is New Nordic Healthbrands AB’s EPS estimate?
New Nordic Healthbrands AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does New Nordic Healthbrands AB have?
New Nordic Healthbrands AB has 6,195,200 shares outstanding.
What happened to New Nordic Healthbrands AB’s price movement after its last earnings report?
New Nordic Healthbrands AB reported an EPS of -kr0.462 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20.404%.
Which hedge fund is a major shareholder of New Nordic Healthbrands AB?
Currently, no hedge funds are holding shares in SE:NNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
New Nordic Healthbrands AB
New Nordic Healthbrands AB (publ), established in 1990 and based in Malmö, Sweden, specializes in the development and global distribution of natural health products. Their offerings encompass a wide array of dietary supplements, herbal medicines, and cosmetic items. The company provides vitality-enhancing products, including those designed for immune system support, alongside specific lines such as balms, repair masks, shampoos, shine serums, chewing gum, and various face and eye creams. These products are marketed under prominent brands like Hair Volume, Skin Care, Beauty In & Out, and the flagship New Nordic brand. With an extensive reach, the company sells its products through pharmacies, department stores, health shops, travel retailers, beauty salons, and online platforms across 41 countries, including Canada, the United States, Europe, and other international markets.
Technical Analysis
Midsona AB Class B
―
Humble Group AB
―
Skane-moellan AB
―
Cheffelo AB
―
Premium Snacks Nordic AB
―